This information was published on 2025-12-23T00:09:56 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2574905 (IR 1770784) |
| (220) |
22 Jul 2025
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for human use for the treatment of oncology, neuro-oncology, tumors, cancer, and rare diseases; pharmaceutical preparations for human use for the treatment of neurofibromatosis; small molecule therapeutic preparations for human use for the treatment of oncology, neuro-oncology, tumors, cancer, and rare diseases; small molecule therapeutic preparations for human use for the treatment of neurofibromatosis. |
| (540) | GOMEKLI |
| (550) | Word |
| (730) |
Merck KGaA
|
Find out more about publications on the About page.